Eli Lilly (NYSE:LLY) said compounded weight-loss treatments that combine vitamin B12 with the active ingredient used in its ...

Lilly asked the FDA to step in after claiming that testing it’s done suggests copycat versions of Zepbound may carry “unknown risks.” ...

Royce International Premier Fund advanced 9.4% in 2025, trailing its benchmark, the MSCI ACWI ex USA Small Cap Index, which was up 29.3% for the same period. Read more here.

A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental allergies, giving patients new ways to manage symptoms and, in some cases, ...

The line outside a local pharmacy in Dubai's Marina neighborhood stretches nearly to the sidewalk café next door on a warm ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

Novo Nordisk's battered stock enjoyed a moment of reprieve after Hims & Hers abandoned plans to launch a compounded version of the just-launched Wegovy pill. Shares in the Danish pharma group were up ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

I'd like to thank you for taking time to join us for Cibus' Fourth Quarter 2025 Financial Results and Business ...

The post Nevada Regulators Fine Peptide Providers at Anti-Aging Festival Where Two Women Became Critically Ill appeared first on ProPublica.